Effects of stimulating interleukin -2/anti- interleukin -2 antibody complexes on renal cell carcinoma.

about

Effects of stimulating interleukin -2/anti- interleukin -2 antibody complexes on renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q35895478

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effects of stimulating interle ...... lexes on renal cell carcinoma.

@ast

Effects of stimulating interle ...... lexes on renal cell carcinoma.

@en

type

Item

label

Effects of stimulating interle ...... lexes on renal cell carcinoma.

@ast

Effects of stimulating interle ...... lexes on renal cell carcinoma.

@en

prefLabel

Effects of stimulating interle ...... lexes on renal cell carcinoma.

@ast

Effects of stimulating interle ...... lexes on renal cell carcinoma.

@en

P1476

Effects of stimulating interle ...... lexes on renal cell carcinoma.

@en

P2093

Curie Ahn

http://www.w3.org/2001/XMLSchema#string

Eun Jin Cho

http://www.w3.org/2001/XMLSchema#string

Eun Mi Lee

http://www.w3.org/2001/XMLSchema#string

Hye Jin Lim

http://www.w3.org/2001/XMLSchema#string

Jae-Ghi Lee

http://www.w3.org/2001/XMLSchema#string

Jaeseok Yang

http://www.w3.org/2001/XMLSchema#string

Ji-Jing Yan

http://www.w3.org/2001/XMLSchema#string

Ki Won Kim

http://www.w3.org/2001/XMLSchema#string

Kyu-Hyun Han

http://www.w3.org/2001/XMLSchema#string

Miyeon Han

http://www.w3.org/2001/XMLSchema#string

P2860

Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

αβ TCR-mediated recognition: relevance to tumor-antigen discovery and cancer immunotherapy

Improvement in overall survival of patients with advanced renal cell carcinoma: prognostic factor trend analysis from an international data set of clinical trials.

Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells

Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma.

Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.

Chemotherapy in metastatic renal cell carcinoma today? A systematic review.

Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12894-016-0121-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26772545

http://www.w3.org/2001/XMLSchema#string

P932

4715282

http://www.w3.org/2001/XMLSchema#string